T Miyagawa Selected Research

T Miyagawa Research Topics

3	Narcolepsy 12/2015 - 11/2000
2	Inflammation (Inflammations) 04/2019 - 08/2015
2	Neoplasms (Cancer) 11/2000 - 06/2000
1	Systemic Scleroderma (Systemic Sclerosis) 04/2019
1	Human Influenza (Influenza) 07/2018
1	Communicable Diseases (Infectious Diseases) 07/2018
1	Pain (Aches) 01/2018
1	Dyspepsia (Indigestion) 01/2018
1	Infections 10/2017
1	Cataplexy 12/2015
1	Hemangiosarcoma (Angiosarcoma) 12/2014
1	Stomach Ulcer (Gastric Ulcer) 02/2012
1	Chronic Obstructive Pulmonary Disease (COPD) 05/2001
1	Lymphatic Metastasis 11/2000
1	Stomach Neoplasms (Stomach Cancer) 11/2000
1	Brain Neoplasms (Brain Tumor) 06/2000

2	HLA-DRB1 Chains (HLA DRB1)IBA 12/2015 - 11/2000
2	irsogladineIBA 08/2015 - 02/2012
1	ElafinIBA 04/2019
1	Leukocyte Elastase (Neutrophil Elastase)IBA 04/2019
1	LigandsIBA 07/2018
1	SugarsIBA 07/2018
1	N-acetylneuraminoyllactoseIBA 07/2018
1	Z 338IBA 01/2018
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2018
1	Daptomycin FDA Link 10/2017
1	HLA-DQB1 antigen (HLA DQB1)IBA 12/2015
1	taxaneIBA 12/2014
1	Cadherins (E-Cadherin)IBA 02/2012
1	ChemokinesIBA 02/2012
1	Type II Tumor Necrosis Factor ReceptorsIBA 03/2001
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2001
1	titanium silicide (TS-1)IBA 11/2000
1	Antineoplastic Agents (Antineoplastics)IBA 11/2000
1	HLA Antigens (Human Leukocyte Antigens)IBA 11/2000
1	Tumor Biomarkers (Tumor Markers)IBA 11/2000
1	HLA-B Antigens (HLA-B)IBA 11/2000
1	Ganciclovir (Cytovene)FDA LinkGeneric 06/2000
1	Thymidine KinaseIBA 06/2000

1	Chemoradiotherapy 12/2014
1	Radiotherapy 12/2014
1	Physical Therapy Modalities (Physical Therapy Technique) 05/2001
1	Aftercare (After-Treatment) 06/2000